Author

Fady H. Fayek

Observed name: Fady H Fayek

Institution: Egyptian Chinese University

Observed institution: Egyptian Chinese University

ORCID: 0009-0006-6622-894X

Observed ORCID: 0009-0006-6622-894X

OpenAlex ID: A5128323636

Discovery of Chemically Distinct DprE1 Inhibitors With Sub‐Nanomolar Predicted Potency Via Virtual Screening and Molecular Dynamics

2026 · Fady H. Fayek, Mai H. A. Mousa, et al. · ChemistrySelect · 3

Virtual Screening, Molecular Dynamics, MM-PBSA and In-silico Studies in Search of Potent Novel Fibroblast Growth Factor Receptors 4 Inhibitor

2024 · Fady H Fayek, Omar M Rashad · Journal of Modern Biology and Drug Discovery · 3

Design and discovery of 1,4-dihydropyrimidinone-based noncovalent DprE1 inhibitors with integrated biological and computational validation against Mycobacterium tuberculosis

2026 · Fady H. Fayek, Mai H.A. Mousa, et al. · Bioorganic Chemistry · 2

Author response for "DprE1 Inhibitors in Tuberculosis: Integrating Structural Binding Determinants, IC50–MIC Translation, and Physicochemical Constraints for Rational Drug Design"

2026 · Fady H. Fayek, Mai H. A. Mousa, et al. · Publons reviews and discussion

Author response for "DprE1 Inhibitors in Tuberculosis: Integrating Structural Binding Determinants, IC50–MIC Translation, and Physicochemical Constraints for Rational Drug Design"

2026 · Fady H. Fayek, Mai H. A. Mousa, et al. · Publons reviews and discussion

Multi-omics network pharmacology and computational validation reveal amodiaquine and desethylamodiaquine as apoptosis-regulating multi-target candidates in colon adenocarcinoma

2026 · Santosh Prasad Chaudhary Kurmi, Fady H. Fayek, et al. · Computational Biology and Chemistry

Works count: 6

Citation count: 8

H-index: 2

I10-index: